| Notwithstanding the wishful thinking of certain irresponsible and incompetent public figures, the only options to control and deal with the spread of the Severe Acute Respiratory Syndrome Virus 2 (SARS-CoV-2) are fast, cheap, reliable, and portable means of diagnosing COVID-19 infection (the name of disease caused by SARS-CoV-2); therapeutics to treat the infected; and vaccines to rapidly build up immunization of large parts of the global population. | |
| In a previous Nanowerk Spotlight we covered nanotechnology-based approaches to testing for COVID-19 infections in high-risk individuals. Today we look at the role of nanotechnology in countering the conventional limitations of antiviral and biological therapeutics. Nanocarriers also have potential to design risk-free and effective immunization strategies for SARS-CoV-2 vaccine candidates such as protein constructs and nucleic acids. | |
| A review paper in ACS Nano (“Nanotechnology for COVID-19: Therapeutics and Vaccine Research”) provides systematic information on nanomedicine strategies employed to deliver small molecules, biologicals (specifically RNAi) and various combination therapies. Some strategies are also proposed for the rational development of this nanomedicine approach and its clinical translation. Since most of the COVID-19 vaccine candidates are sophisticated biological moieties (DNA, mRNA, recombinant proteins, engineered APCs etc.), the scope of nanocarrier delivery becomes highly pertinent. | |
| The authors first describe in great detail the current state of knowledge about the virus’s life cycle, pathophysiology and structure, and then address the organ systems primarily affected by SARS-CoV-2 (it affects the respiratory system first and then spreads systemically to the heart, liver and kidney). | |
Developing SARS-CoV-2 therapeutics |
|
| Today there is no exclusive antiviral treatment against SARS-CoV-2 although therapeutic and prophylactic strategies to deal with existing and potentially upcoming coronavirus infections are under development in research laboratories worldwide. | |
| Using recently available genetic information and protein structure modelling, several therapeutic strategies based on drug repurposing are projected for the immediate treatment of infected patients. | |
| According to the authors, target identification to halt the pathogenesis of the viral infection holds the key in this development: “Viral protease (3CLpro and PLpro), host cell produced protease (TMPRSS2), RNA polymerase (RdRp), interaction site of viral S protein with host receptor ACE2 are among the major targets identified for repurposing already existing antiviral molecules and new small molecules under development.” | |
| Other proposed strategies are targeting the SARS-CoV-2 surface S protein using neutralizing antibody (nAbs) and targeting the SARS-CoV-2 viral RNA genome using RNA interference (RNAi) or antisense oligonucleotides. | |
Developing a vaccine against COVID-19 |
|
| Massive efforts are being employed across the world to develop safe and effective vaccines and several vaccine candidates (see Table 1 in the review for details) have already made it to human clinical trials as a result of fast-tracked development strategies and advanced vaccine technological platforms (read more here in The New England Journal of Medicine: “Developing Covid-19 Vaccines at Pandemic Speed”). | |
| Similar to what researchers are doing in developing SARS-CoV-2 therapeutics, the target strategy for most of the vaccine candidates is to induce nAbs against the viral S protein, averting the ACE2 mediated host uptake. | |
| In the case of SARS-CoV vaccine development, higher nAbs titers and better protection was reported with S protein subunit vaccines when compared to any other target strategy. SARS/MERS vaccine development research suggests S protein subunits, RBD of the S1 subunit and S protein/gene as the most preferred target sites. | |
| The development of COVID-19 vaccine candidates are relying on several high-tech platforms including attenuated and inactivated viruses, replicating and non replicating viral vectors, DNA and mRNA, virus-like particles and recombinant protein-based approaches. |
Image Credit: Envato/ Amanda Scott
News This Week
Warning of serious brain disorders in people with mild coronavirus symptoms
Doctors may be missing signs of serious and potentially fatal brain disorders triggered by coronavirus, as they emerge in mildly affected or recovering patients, scientists have warned. Neurologists are on Wednesday publishing details of [...]
Nanoparticles Offer a Promising Way for Treating Cancer, Liver Disorders
University of Wisconsin-Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination -- including a COVID-19 vaccine from Moderna [...]
Covid-19 vaccines may be stifled by pre-existing antibodies
Despite its advantages over other vaccine technologies for Covid-19, adenovirus vector vaccines are likely to be tripped up by pre-existing antibodies to the vectors used and the need for a second injection to boost [...]
This coronavirus mutation has taken over the world. Scientists are trying to understand why.
When the first coronavirus cases in Chicago appeared in January, they bore the same genetic signatures as a germ that emerged in China weeks before. But as Egon Ozer, an infectious-disease specialist at the Northwestern University [...]
Online Special Edition “NanoScientific Symposium on Nano Applications”
Park Systems presents “NanoScientific Symposium on Nano Applications for a Changing World” sponsored by Physics World and Nanotechnology World Association. Park Systems launched this online event for researchers and scientists in nanoscience and nanotechnology [...]
Medical nanotechnology research for COVID-19
Notwithstanding the wishful thinking of certain irresponsible and incompetent public figures, the only options to control and deal with the spread of the Severe Acute Respiratory Syndrome Virus 2 (SARS-CoV-2) are fast, cheap, reliable, [...]
COVID ‐19: A new paper on the global threat to the nervous system
From the Annals of Neurology: In less than 6 months, the severe acute respiratory syndrome‐coronavirus type 2 (SARS‐CoV‐2) has spread worldwide infecting nearly 6 million people and killing over 350,000. Initially thought to be restricted [...]
Steroid found to help prevent deaths of sickest coronavirus patients
A cheap steroid has become the first life-saving treatment in the Covid-19 pandemic, described by scientists as a major breakthrough and raising hopes for the survival of thousands of the most seriously ill. Dexamethasone [...]
Imperial to begin first human trials of new COVID-19 vaccine
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. The study will be the first time the vaccine has been trialled in humans [...]
Study: Dominant form of virus ‘10 times’ more infectious than original strain
A form of the novel coronavirus which has become the dominant type in much of the world may have done so thanks to a mutation that allows it to better latch onto human hosts’ [...]
Widely available indigestion drug may curb COVID-19 symptoms in mild to moderate disease
A widely available and inexpensive drug that is used to ease the symptoms of indigestion may prove a worthy contender for treating COVID-19 infection in those whose disease doesn’t require admission to hospital, suggest [...]
Ohio State researchers testing breathalyzer to detect COVID-19
One of the most common COVID-19 tests involves a long swab pressed deep into the nasal cavities – and while the test can be administered quickly, it has been described as unpleasant and uncomfortable. [...]
Coronavirus research updates: Positive coronavirus test is no guarantee of infectiousness
Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear: 1 June — Positive coronavirus test is no guarantee of infectiousness People with COVID-19 are unlikely to [...]
Coronavirus May Be a Blood Vessel Disease, Which Explains Everything
In April, blood clots emerged as one of the many mysterious symptoms attributed to Covid-19, a disease that had initially been thought to largely affect the lungs in the form of pneumonia. Quickly after came [...]
Researchers develop experimental rapid COVID-19 test using nanoparticle technique
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay [...]
Researchers flag similarities between COVID-19 deaths and severe rheumatic illnesses
Rheumatologists at the University of Alberta are flagging similarities between the deaths of some COVID-19 patients and those with rheumatic illnesses, and are testing proven rheumatic treatments to see whether they help against [...]
